A fifth COVID-19 vaccine has been approved in Pakistan: China’s Sinovac shot called CoronaVac. It has an efficacy of 50.7%.
The country also awaits supplies of the Astrazeneca vaccine through COVAX.
This shot has been surrounded by controversy because of reports of blood clots after vaccination.
Related
